The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Endotoxin (Lipopolysaccharide) Neutralization by Innate Immunity Host-Defense Peptides
Open accessAbstract
Binding of lipopolysaccharide (LPS) to macrophages results in proinflammatory cytokine secretion. In extreme cases it leads to endotoxic shock. A few innate immunity antimicrobial peptides (AMPs) neutralize LPS activity. However, the underlying mechanism and properties of the peptides are not yet clear. Toward meeting this goal we investigated four AMPs and their fluorescently labeled analogs. These AMPs varied in composition, length, structure, and selectivity toward cells. The list included human LL-37 (37-mer), magainin (24-mer), a 15-mer amphipathic alpha-helix, and its D,L-amino acid structurally altered analog. The peptides were investigated for their ability to inhibit LPS-mediated cytokine release from RAW264.7 and bone marrow-derived primary macrophages, to bind LPS in solution, and when LPS is already bound to macrophages (fluorescence spectroscopy and confocal microscopy), to compete with LPS for its binding site on the CD14 receptor (flow cytometry) and affect LPS oligomerization. We conclude that a strong binding of a peptide to LPS aggregates accompanied by aggregate dissociation prevents LPS from binding to the carrier protein lipopolysaccharide-binding protein, or alternatively to its receptor, and hence inhibits cytokine secretion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
The immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742
Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction
Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., & Gusovsky, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10689 · Cited by 1,924
Structure and Function of Lipopolysaccharide Binding Protein
Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., & Ulevitch, R. J. (1990) · Science · doi:10.1126/science.2402637 · Cited by 1,672
Peptide Antibiotics and Their Role in Innate Immunity
Boman, H. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.61 · Cited by 1,665
Schiffer, M., & Edmundson, A. B. (1967) · Biophysical Journal · doi:10.1016/s0006-3495(67)86579-2 · Cited by 1,173
Bacterial lipopolysaccharides and innate immunity
Alexander, C., & Rietschel, E. T. (2001) · Journal of Endotoxin Research · doi:10.1179/096805101101532675 · Cited by 1,120
The role of antimicrobial peptides in animal defenses
Hancock, R. E. W., & Scott, M. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.8856 · Cited by 971
Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.
Hailman, E., Lichenstein, H. S., Wurfel, M. M., Miller, D. S., Johnson, D. A., Kelley, M., Busse, L. A., Zukowski, M. M., & Wright, S. D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.269 · Cited by 743
Zhang, F. X., Kirschning, C. J., Mancinelli, R., Xu, X.-P., Jin, Y., Faure, E., Mantovani, A., Rothe, M., Muzio, M., & Arditi, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7611 · Cited by 595
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
Larrick, J. W., Hirata, M., Balint, R. F., Lee, J., Zhong, J., & Wright, S. C. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1291-1297.1995 · Cited by 573
Toll receptors, CD14, and macrophage activation and deactivation by LPS
Dobrovolskaia, M. A., & Vogel, S. N. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01613-1 · Cited by 564
Rietschel, E. T., Brade, H., Holst, O., Brade, L., Müller-Loennies, S., Mamat, U., Zähringer, U., Beckmann, F., Seydel, U., Brandenburg, K., et al. (1996) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-80186-0_3 · Cited by 469
Oren, Z., & Shai, Y. (1997) · Biochemistry · doi:10.1021/bi962507l · Cited by 416
Self-citationFrapper fort ou doucement:A Gramnegative dilemma.
Hopkin, B. D. A. (1978) · The Lancet · Cited by 358
Lipopolysaccharide Binding Protein-mediated Complexation of Lipopolysaccharide with Soluble CD14
Tobias, P. S., Soldau, K., Gegner, J. A., Mintz, D., & Ulevitch, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10482 · Cited by 324
Jiang, Q., Akashi, S., Miyake, K., & Petty, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3541 · Cited by 320
Scott, M. G., Vreugdenhil, A. C. E., Buurman, W. A., Hancock, R. E. W., & Gold, M. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.549 · Cited by 270
Nagaoka, I., Hirota, S., Niyonsaba, F., Hirata, M., Adachi, Y., Tamura, H., & Heumann, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3329 · Cited by 258
Antiendotoxin activity of cationic peptide antimicrobial agents
Gough, M., Hancock, R. E., & Kelly, N. M. (1996) · Infection and Immunity · doi:10.1128/iai.64.12.4922-4927.1996 · Cited by 244
Papo, N., & Shai, Y. (2003) · Biochemistry · doi:10.1021/bi0267846 · Cited by 228
Self-citationPapo, N., Oren, Z., Pag, U., Sahl, H.-G., & Shai, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204928200 · Cited by 210
Self-citationBiological Properties of Structurally Related α-Helical Cationic Antimicrobial Peptides
Scott, M. G., Yan, H., & Hancock, R. E. W. (1999) · Infection and Immunity · doi:10.1128/.67.4.2005-2009.1999 · Cited by 189
Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation
Tobias, P. S., & Ulevitch, R. J. (1993) · Immunobiology · doi:10.1016/s0171-2985(11)80341-4 · Cited by 178
Structure-Activity Relationship of Synthetic Toll-like Receptor 4 Agonists
Stöver, A. G., Correia, J. D. S., Evans, J. T., Cluff, C. W., Elliott, M. W., Jeffery, E. W., Johnson, D. A., Lacy, M. J., Baldridge, J. R., Probst, P., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310760200 · Cited by 162
Nagaoka, I., Hirota, S., Niyonsaba, F., Hirata, M., Adachi, Y., Tamura, H., Tanaka, S., & Heumann, D. (2002) · Clinical and Vaccine Immunology · doi:10.1128/cdli.9.5.972-982.2002 · Cited by 160
Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin
Schimke, J., Mathison, J. C., Morgiewicz, J., & Ulevitch, R. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13875 · Cited by 134
Takayama, K., Mitchell, D. H., Din, Z. Z., Mukerjee, P., Li, C., & COLEMAN, D. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42159-4 · Cited by 117
David, S. A. (2001) · Journal of Molecular Recognition · doi:10.1002/jmr.549 · Cited by 116
Andrä, J., Koch, M. H. J., Bartels, R., & Brandenburg, K. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1593-1599.2004 · Cited by 104
Hardaway, R. M. (2000) · The American Surgeon · doi:10.1177/000313480006600105 · Cited by 104
Py, W., Kitchens, R., & Rs, M. (1997) · PubMed · Cited by 57
Potential Therapeutic Role of Cationic Peptides in Three Experimental Models of Septic Shock
Giacometti, A., Cirioni, O., Ghiselli, R., Mocchegiani, F., Prete, M. S. D., Viticchi, C., Kamysz, W., Łempicka, E., Saba, V., & Scalise, G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2132-2136.2002 · Cited by 57
Novel therapies for sepsis: antiendotoxin therapies
Manocha, S., Feinstein, D., Kumar, A., & Kumar, A. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.12.1795 · Cited by 53
de Haas, C. J. C., van Leeuwen, H. J., Verhoef, J., van Kessel, K. P. M., & van Strijp, J. A. G. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00207-6 · Cited by 45
David, S. A., Awasthi, S. K., & Balaram, P. (2000) · Journal of Endotoxin Research · doi:10.1177/09680519000060030601 · Cited by 27
Cited by
Antimicrobial host defence peptides: functions and clinical potential
Mookherjee, N., Anderson, M. A., Haagsman, H. P., & Davidson, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0058-8 · Cited by 1,502
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense
Lai, Y., & Gallo, R. L. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.12.003 · Cited by 1,276
The co-evolution of host cationic antimicrobial peptides and microbial resistance
Peschel, A., & Sahl, H.-G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1441 · Cited by 1,062
LL-37, the only human member of the cathelicidin family of antimicrobial peptides
Dürr, U. H. N., Sudheendra, U. S., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.030 · Cited by 1,049
Hansdottir, S., Monick, M. M., Hinde, S. L., Lovan, N., Look, D. C., & Hunninghake, G. W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7090 · Cited by 609
Metadata
- Authors
- Rosenfeld, Y., Papo, N., & Shai, Y.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 281
- Issue
- 3
- Pages
- 1636-1643
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2047580124
- Cited by
- 370
- References
- 39
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.